Efficacy and safety of risperidone in the treatment of schizoaffective disorder: initial results from a large, multicenter surveillance study. Group for the Study of Risperidone in Affective Disorders (GSRAD).

Add item related to this paper

  • MiniManuscript ID
    63725
  • Pubmed ID
    11561935